A Phase I Trial of AVN944, an IMPDH Inhibitor, in Adults With Advanced Stage Solid Tumors

NCT00923728 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Refractory Solid Tumors

Interventions

DRUG: AVN944

Sponsor

Vertex Pharmaceuticals Incorporated

Collaborators

[object Object]